Dimethylcarbamoyl Chloride → Trifluoroacetic acid
Reaction equation
[OH:1][C:2]([C:4]([F:7])([F:6])[F:5])=[O:3].[C:8]([NH:12][C:13]1[N:14]=[C:15]2[CH2:37][CH2:36][NH:35][CH2:34][C:16]2=[N:17][C:18]=1[N:19]1[CH2:24][CH2:23][CH:22]([O:25][C:26]2[CH:31]=[CH:30][C:29]([F:32])=[CH:28][C:27]=2[F:33])[CH2:21][CH2:20]1)([CH3:11])([CH3:10])[CH3:9].[CH3:38][N:39]([CH3:43])[C:40](Cl)=[O:41].CCN(C(C)C)C(C)C>C(Cl)Cl.CN(C=O)C>[C:8]([NH:12][C:13]1[N:14]=[C:15]2[CH2:37][CH2:36][N:35]([C:40]([N:39]([CH3:43])[CH3:38])=[O:41])[CH2:34][C:16]2=[N:17][C:18]=1[N:19]1[CH2:20][CH2:21][CH:22]([O:25][C:26]2[CH:31]=[CH:30][C:29]([F:32])=[CH:28][C:27]=2[F:33])[CH2:23][CH2:24]1)([CH3:11])([CH3:9])[CH3:10].[C:2]([OH:3])([C:4]([F:7])([F:6])[F:5])=[O:1]Participants
Procedure
A solution of N-(tert-butyl)-3-(4-(2,4-difluorophenoxyl)piperidin-1-yl)-5,6,7,8-tetrahydropyrido[3,4-b]pyrazin-2-amine TFA salt (16 mg, 0.030 mmol), dimethylcarbamic chloride (3.2 mg, 0.030 mmol), and DIPEA (5.3 μL, 0.030 mmol) in DCM (151 μL) was stirred at room temperature overnight. The crude reaction mixture was diluted in DMF, filtered through a hydrophilic PTFE 0.45 μm filter (Millipore® Millex-LCR), and purified via HPLC Method A to give the title compound as a TFA salt (10 mg) as a clear oil. 1H NMR (400 MHz, methanol-d4) δ ppm 1.48 (s, 9H), 1.87-1.97 (m, 2H), 2.07-2.17 (m, 2H), 2.82 (t, J=5.9 Hz, 2H), 2.90 (s, 6H), 2.95 (ddd, J=12.2, 8.5, 3.3 Hz, 2H), 3.29-3.35 (m, 2H), 3.53 (t, J=5.8 Hz, 2H), 4.25 (s, 2H), 4.46 (tt, J=7.5, 3.8 Hz, 1H), 6.84-6.91 (m, 1H), 6.99 (ddd, J=11.4, 8.6, 3.0 Hz, 1H), 7.18 (td, J=9.3, 5.4 Hz, 1H); ESI-MS m/z [M+H]+489.4.
Workup
- customThe crude reaction mixture
- filtrationfiltered through a hydrophilic PTFE 0.45 μm
- filtrationfilter (Millipore® Millex-LCR)
- custompurified via HPLC Method A
Sources & evidence
- ORD record
- ord-d68eb788797a4627b4fceea79e75f714
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181249B2
Reaction notes
Loading…